Prostate Cancer - Results from #19400

Castration-resistant prostate cancer: AUA Guideline amendment - Abstract January 24, 2015

Extended use of P504S positive primary circulating prostate cell detection to determine the need for initial prostate biopsy in a prostate cancer screening program in Chile - Abstract January 24, 2015

Value of a standardized lexicon for reporting levels of diagnostic certainty in prostate MRI - Abstract January 24, 2015

NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer - Abstract January 24, 2015

How accurate is multiparametric MR imaging in evaluation of prostate cancer volume? - Abstract January 24, 2015

Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapy - Abstract January 24, 2015

ERG induces taxane resistance in castration-resistant prostate cancer - Abstract January 24, 2015

Epigenetics of prostate cancer - Abstract January 24, 2015

Prostate cancer incidence in Turkey: An epidemiological study - Abstract January 23, 2015

Robot-assisted radical prostatectomy in an initial Japanese series: The impact of prior abdominal surgery on surgical outcomes - Abstract January 23, 2015

Transperineal template-guided mapping biopsy of the prostate - Abstract January 23, 2015

A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer - Abstract January 23, 2015

Health-care utilization by prognosis profile in a managed care setting: Using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC - Abstract January 23, 2015

Carbohydrate intake, glycemic index and prostate cancer risk - Abstract January 23, 2015

Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance) - Abstract January 23, 2015

Prostate cancer epigenome - Abstract January 23, 2015

Enzalutamide phase 2 Terrain trial demonstrated statistically significant increase in PFS as compared to bicalutamide in metastatic prostate cancer January 22, 2015

Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens - Abstract January 22, 2015

Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer - Abstract January 22, 2015

Stereotactic ultrasound for target volume definition in a patient with prostate cancer and bilateral total hip replacement - Abstract January 22, 2015

Page 971 of 1457